Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies

Patients with non–Hodgkin lymphoma and chronic lymphocytic leukemia (NHL/CLL) elicit inadequate antibody responses after initial SARS-CoV-2 vaccination and remain at high risk of severe COVID-19 disease. We investigated IgG, IgA, and IgM responses after booster vaccination against recent SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Andres, Akhtar, Akil, Lai, Lilin, Orellana-Noia, Victor M., Linderman, Susanne L., McCook-Veal, Ashley A., Switchenko, Jeffrey M., Saini, Manpreet, Valanparambil, Rajesh M., Blum, Kristie A., Allen, Pamela B., Lechowicz, Mary Jo, Romancik, Jason T., Ayers, Amy, Leal, Alyssa, O'Leary, Colin B., Churnetski, Michael C., Baird, Katelin, Kives, Melissa, Wrammert, Jens, Nooka, Ajay K., Koff, Jean L., Dhodapkar, Madhav V., Suthar, Mehul S., Cohen, Jonathon B., Ahmed, Rafi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833496/
https://www.ncbi.nlm.nih.gov/pubmed/36644323
http://dx.doi.org/10.1158/2767-9764.CRC-22-0471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833496/
https://www.ncbi.nlm.nih.gov/pubmed/36644323
http://dx.doi.org/10.1158/2767-9764.CRC-22-0471

Ejemplares similares